Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes. | Pharmaceuticals (Basel) | 2021 | 34577547 | PubTator, text mining | PubMed |
| Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization. | Int J Mol Sci | 2021 | 34576269 | PubTator, text mining | PubMed |
| Roles and Mechanisms of Deubiquitinases (DUBs) in Breast Cancer Progression and Targeted Drug Discovery. | Life (Basel) | 2021 | 34575114 | PubTator, text mining | PubMed |
| Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis. | Front Mol Neurosci | 2021 | 34566579 | PubTator, text mining | PubMed |
| Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer. | Cancer Res | 2021 | 34561273 | PubTator, text mining | PubMed |
| Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy. | Nat Microbiol | 2021 | 34556855 | PubTator, text mining | PubMed |
| AMPK: restoring metabolic homeostasis over space and time. | Mol Cell | 2021 | 34547233 | PubTator, text mining | PubMed |
| The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis. | Oncogene | 2021 | 34545187 | PubTator, text mining | PubMed |
| The regulatory networks of the Hippo signaling pathway in cancer development. | J Cancer | 2021 | 34539895 | PubTator, text mining | PubMed |
| Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. | Proc Natl Acad Sci U S A | 2021 | 34518219 | PubTator, text mining | PubMed |
| The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress. | J Biol Chem | 2021 | 34509474 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Diagnostic yield of genetic testing in 324 infants with hypotonia. | Clin Genet | 2021 | 34480364 | PubTator, text mining | PubMed |
| Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer. | Nat Commun | 2021 | 34475389 | PubTator, text mining | PubMed |
| Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes. | Genome Med | 2021 | 34470661 | PubTator, text mining | PubMed |
| Deubiquitinases in hematological malignancies. | Biomark Res | 2021 | 34454635 | PubTator, text mining | PubMed |
| Coordinating DNA Replication and Mitosis through Ubiquitin/SUMO and CDK1. | Int J Mol Sci | 2021 | 34445496 | PubTator, text mining | PubMed |
| USP48 Governs Cell Cycle Progression by Regulating the Protein Level of Aurora B. | Int J Mol Sci | 2021 | 34445214 | PubTator, text mining | PubMed |
| Intersection of Redox Chemistry and Ubiquitylation: Post-Translational Modifications Required for Maintaining Cellular Homeostasis and Neuroprotection. | Cells | 2021 | 34440890 | PubTator, text mining | PubMed |
| Photodynamic Therapy Combined with Bcl-2/Bcl-xL Inhibition Increases the Noxa/Mcl-1 Ratio Independent of Usp9X and Synergistically Enhances Apoptosis in Glioblastoma. | Cancers (Basel) | 2021 | 34439278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=32